Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening

Affiliations

Review

Michael Bigby. Arch Dermatol. 2010 Mar.

. 2010 Mar;146(3):322-4.

doi: 10.1001/archdermatol.2010.18.

¹ Department of Dermatology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215, USA. mbigby@bidmc.harvard.edu

No abstract available

Comment on

Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement.
U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Ann Intern Med. 2009 Feb 3;150(3):188-93. doi: 10.7326/0003-4819-150-3-200902030-00008. Ann Intern Med. 2009. PMID: 19189908
Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T, Tai E, Miller T. Wolff T, et al. Ann Intern Med. 2009 Feb 3;150(3):194-8. doi: 10.7326/0003-4819-150-3-200902030-00009. Ann Intern Med. 2009. PMID: 19189909 Review.